Orphanet: ANNOUNCE: Ensayo de fase 3, aleatorizado, doble ciego, controlado con placebo, en el que se compara doxorubicina y olaratumab con doxorubicina y placebo, en pacientes con sarcoma de tejidos blandos en estadio avanzado o metastásico
x

Search for a clinical trial

* (*) mandatory field

ANNOUNCE: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Lilly s.a
    • Phase : III
  • Principal investigator of clinical trial

  • Dr Roberto DAZ BEVERIDGE
  • Servicio de Oncologa Mdica
  • Hospital Universitario y Politcnico La Fe
  • Avenida de Fernando Abril Martorell 106
  • 46026 VALENCIA
  • SPAIN
  • More information
  • Phone  : 34 961244193
  • Fax  : -
  • Website
  • Sponsor of clinical trial

  • LILLY S.A
  • Lilly Spain
  • Lilly S.A.
  • Avenida de la Industria, 30
  • 28108 ALCOBENDAS
  • SPAIN
  • More information
  • Phone  : 34 916633485
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: October 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.